First human test of BGB-23339 completed in healthy volunteers
NCT ID NCT05093270
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 35 times
Summary
This early-stage study tested a new drug, BGB-23339, in 92 healthy adults to see if it is safe and how the body handles it. Participants took single or multiple doses, and the effect of food was also checked. The goal was to gather safety information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NOT DETERMINED are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Nucleus Network
Melbourne, Victoria, VIC 3004, Australia
-
Q PHARM
Herston, Queensland, QLD 4006, Australia
-
The Affiliated Hospital of Qingdao University Branch West Coast
Qingdao, Shandong, 266555, China
Conditions
Explore the condition pages connected to this study.